Fibromyalgia Trial, Recruiting NCT07483216 Sponsor: European University Miguel de Cervantes Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT07483216
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman aged 18 or older who has been diagnosed with fibromyalgia based on current medical guidelines.
  • Your condition and any medications you take have been stable in the weeks before joining the study.
  • You are able to take part in supervised exercise sessions and complete the required assessments.
  • You are willing and able to sign a written consent form agreeing to take part.

Who may not be able to join:

  • You have a heart, neurological, bone, muscle, or other serious health condition that means exercise would not be safe for you.
  • Your medication has been significantly changed shortly before the study begins.
  • You have any other condition that, in the opinion of the medical team, would make it unsafe for you to follow the study's programme (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alejandro Santos Lozano, PhD, Miguel de Cervantes European University

Phone: 0034983001000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
European University Miguel de Cervantes
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 July 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Peak torque; Peak torque; Agonist-antagonist ratio; Total work; Height

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov